China denies its Wuhan bio-lab conducted ‘gain-of-function studies’ of coronavirus
Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.
Self-assembled proteomimetics: Synthetic antibodies that are easier and cheaper to produce
For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...
unige.ch2d
Synthetic antibodies easier to produce
UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.
Chitosan Derivatives: A Suggestive Evaluation for Novel Inhibitor Discovery Against Wild-Type and Variants of SARS-CoV-2 Virus
The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...
Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2?
Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
No, Moderna Did Not Create Its COVID Vaccine Two Years Before the Pandemic
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
pharmaphorum7d
The critical bioanalytical strategies unlocking the potential of LNP-mRNA
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
emjreviews.com7d
Detectable Antibodies Lower COVID-19 Risk in Immunosuppressed
A UK study finds detectable antibodies reduce COVID-19 infection and severity in immunosuppressed individuals, highlighting ...
Too Old to Operate8d
Immunization Gaps in Prisons for COVID-19
The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...
News Medical8d
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain
Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...
Finanznachrichten9d
Revive Therapeutics Ltd.: Revive Therapeutics Announces Update on R&D Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
A study titled "Thiol-based drugs decrease binding of SARS-CoV-2 spike protein to its receptor and inhibit SARS-CoV-2 cell entry" showed that thiol-based drugs, like Bucillamine, decrease the binding ...